| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.1 | 0.7 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |